TD Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

TD Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50,636	Closed	-$1.4M	–	1573
2021 Q2	$1.4M	Sell	50,636 -21,700	-30%	-$426K	﹤0.01%	1192
2021 Q1	$1.19M	Buy	72,336 +12,924	+22%	+$294K	﹤0.01%	1230
2020 Q4	$1.09M	Buy	59,412 +7,700	+15%	+$138K	﹤0.01%	1167
2020 Q3	$704K	Hold	51,712	–	–	﹤0.01%	1162
2020 Q2	$927K	Buy	+51,712	New	+$780K	﹤0.01%	1080

TD Asset Management's TBIO Position: Q3 2021 in Review

TD Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 50,636 shares — an estimated $1.4M sold.

TD Asset Management first reported a position in TBIO in Q2 2020 and held it in 5 quarters. The position peaked at $1.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

TD Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
TD Asset Management sold 50,636 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.4M.
TD Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
TD Asset Management's Translate Bio, Inc. Common Stock position peaked at $1.4M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on TD Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.